MTEM (Molecular Templates, Inc.) נכסים נקיים של החברה

The biotechnology entity Molecular Templates (MTEM) has ceased operations and is liquidating its assets following the departure of key allies, with the indicator standing at 0.01. The price visualization available on the page helps track the price action of Molecular Templates (MTEM), which develops specialized toxins to destroy solid tumors with immense market potential. The business relies on the ETP system, which enables the delivery of hazardous agents into tumors while bypassing their protective barriers.

Book value reflects the residual value of net assets minus all liabilities, allowing an investor to assess the real intrinsic value of the business regardless of market volatility. The trend in the firm's equity helps identify the bankruptcy risk of Molecular Templates (MTEM), where critical staff reductions and the freezing of R&D developments turn any local minimum into a signal of a deep liquidity crisis.